Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma
- Resource Type
- Article
- Source
- In
Bioactive Materials October 2023 28:376-385 - Subject
- Language
- ISSN
- 2452-199X